SecBot SecBot
SC 13G/A ·Filed Oct 7, 2026

ARCT

Arcturus Therapeutics Holdings Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed20d 5h ago SEC0001623632-26-001546
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to Schedule 13D, which would signal activist intent. For now, Federated Hermes remains a passive holder — no immediate catalyst from this filing.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d
ARCT ▼ -12.89% at T+5d
NEUTRAL call -12.89% · α vs SPY -11.91% · entry $12.77 → $11.12
Next anchor: T+20d in 8d
Latest observation: T+12 -40.41% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
+0.82%
call +0.82% · α +1.25%
$12.87
settled 19d ago
T+5d
-12.89%
call -12.89% · α -11.91%
$11.12
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Federated Hermes, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 1,678,069 shares of Arcturus Therapeutics common stock, representing 5.90% of shares outstanding as of September 30, 2026. The filing is a routine passive stake update with no change in ownership level from prior filings, indicating continued passive investment without activist intent.

Key Financial Metrics

Stake
5.9%
Investor
Federated Hermes, Inc.
Investor Type
mutual fund

Key Facts

  • Federated Hermes, Inc. and related entities beneficially own 1,678,069 shares of Arcturus Therapeutics common stock.
  • The stake represents 5.90% of outstanding shares as of September 30, 2026.
  • The filing is an amendment to Schedule 13G, confirming passive investment intent with no control or influence purpose.
  • All reporting persons expressly disclaim beneficial ownership of the securities held by managed funds.

Financial Impact

No material financial impact — passive stake disclosure with no change in ownership level or intent.

Risk Factors

  • No material risks identified — routine passive stake amendment.

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001623632-26-001546
Document: arcturusexhibit1.htm0001623632-26-001546
Document: arcturusexhibit3trd.htm0001623632-26-001546
Document: arcturusexhibit3acd.htm0001623632-26-001546
Document: 0001623632-26-001546-index-headers.html0001623632-26-001546
Document: 0001623632-26-001546-index.html0001623632-26-001546
Document: 0001623632-26-001546.txt0001623632-26-001546
5 reports for ARCT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ARCT — sortable, filterable
TypeNow
Oct 7, 2026
20d ago
SC 13G/A
NEUTRAL ★ 3/10
$12.77awaiting T+20—$10.87 (−14.85%)
Sep 28, 2026
29d ago
Court Ruling
NEUTRAL ★ 2/10
$13.70awaiting T+20—$10.87 (−20.66%)
Aug 25, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$15.44 $14.69▼ −4.86%▼ −6.10%$10.87 (−29.60%)
Aug 15, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$8.14 $15.84▲ +94.59%▲ +96.57%$10.87 (+33.54%)
Jul 2, 2026
16w ago
8-K
BULLISH ★ 6/10
$7.28 $5.92▼ −18.68%▼ −18.27%$10.87 (+49.31%)
Showing 5 of 5

US Market Status

Market Open — Closes in 3h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026